Leaderboards/Brain Metastases and Treatment

Brain Metastases and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Erez N. Baruch
The University of Texas MD Anderson Cancer Center
2
Ján Remšík
Memorial Sloan Kettering Cancer Center
3
Leire Bejarano
University Hospital of Lausanne
4
Bolong Tao
Air Force Medical University
5
Andrew E. Whiteley
California Polytechnic State University
6
Vladimir Wischnewski
University Hospital of Lausanne
7
Beatriz Ocaña-Tienda
Centro Nacional de Epidemiología
8
Siting Gan
Memorial Sloan Kettering Cancer Center
9
Lena Jassowicz
Heidelberg University
10
Harriet O’Rourke
The University of Melbourne

Papers

1
Publication in Cancer Cell (2024) [80 citations, W4391056102]
Cancer Cell|2024
80 cit.
2
Publication in Science (2024) [72 citations, W4399849429]
Science|2024
72 cit.
3
Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain
Cancer Cell|2024
62 cit.
4
Publication in Nature (2025) [59 citations, W4413345515]
Nature|2025
59 cit.
5
Interferon-γ orchestrates leptomeningeal anti-tumour response
Nature|2025
30 cit.
6
Publication in Immunity (2025) [28 citations, W4408572842]
Immunity|2025
28 cit.
7
The local microenvironment suppresses the synergy between irradiation and anti-PD1 therapy in breast-to-brain metastasis
Cell Reports|2025
10 cit.
8
Publication in Cancer Imaging (2024) [8 citations, W4401894613]
Cancer Imaging|2024
8 cit.
9
Publication in Expert Review of Anticancer Therapy (2024) [6 citations, W4394685428]
Expert Review of Anticancer Therapy|2024
6 cit.
10
Publication in PLoS Computational Biology (2024) [5 citations, W4391343143]
PLoS Computational Biology|2024
5 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Manuel Valiente
Instituto de Filosofía
2
Christina Fitzmaurice
Gundersen Health System
3
Damdindorj Boldbaatar
Mongolian National University
4
Qixue Wang
Tianjin Medical University General Hospital
5
David R. Raleigh
University of California, San Francisco
6
Nelson S. Moss
Memorial Sloan Kettering Cancer Center
7
Stephen T. Magill
Northwestern University
8
Mingbin Zheng
Songshan Lake Materials Laboratory
9
Nathalie L. Albert
LMU Klinikum
10
Ahu Yuan
China Pharmaceutical University

Papers

1
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
Nature Genetics|2022
302 cit.
2
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
Nature Medicine|2023
106 cit.
3
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
Nature Medicine|2022
82 cit.
4
High‐<i>Z</i>‐Sensitized Radiotherapy Synergizes with the Intervention of the Pentose Phosphate Pathway for In Situ Tumor Vaccination
Advanced Materials|2022
80 cit.
5
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features
Neuro-Oncology|2022
71 cit.
6
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
Frontiers in Immunology|2022
66 cit.
7
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
European Journal of Nuclear Medicine and Molecular Imaging|2024
62 cit.
8
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Nature Genetics|2024
55 cit.
9
In Situ Vaccination with Mitochondria‐Targeting Immunogenic Death Inducer Elicits CD8<sup>+</sup> T Cell‐Dependent Antitumor Immunity to Boost Tumor Immunotherapy
Advanced Science|2023
43 cit.
10
TIMP1 Mediates Astrocyte-Dependent Local Immunosuppression in Brain Metastasis Acting on Infiltrating CD8+ T Cells
Cancer Discovery|2024
40 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Jill S. Barnholtz‐Sloan
Emory University
2
Minesh P. Mehta
Columbia University
3
Walter J. Curran
Piedmont Cancer Institute
4
L. Dade Lunsford
University of Pittsburgh
5
Eric P. Winer
University of Vermont
6
Matthias Preusser
Medical University of Vienna
7
Victor A. Levin
Orbus Therapeutics (United States)
8
Michael Weller
University Hospital of Zurich
9
Joan Massagué
Memorial Sloan Kettering Cancer Center
10
Patrick Y. Wen
Dana-Farber Cancer Institute

Papers

1
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
Neuro-Oncology|2013
12.1k cit.
2
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Journal of Clinical Oncology|2010
3.8k cit.
3
Genes that mediate breast cancer metastasis to lung
Nature|2005
3k cit.
4
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
New England Journal of Medicine|2014
2.8k cit.
5
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
Neuro-Oncology|2019
2.6k cit.
6
A multigenic program mediating breast cancer metastasis to bone
Cancer Cell|2003
2.6k cit.
7
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
Neuro-Oncology|2021
2.6k cit.
8
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.
Journal of Biological Chemistry|1986
2.5k cit.
9
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
The Lancet|2004
2.4k cit.
10
Mechanism of activation of the TGF-β receptor
Nature|1994
2.3k cit.

Reagents for Brain Metastases and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

COL3A1 Antibody

Cited in 5 papers
#30565$317
View Evidence →
Cell Signaling TechnologyEvidence 67

Phospho-PLCbeta3 (Ser537) Antibody

#2481$362
View Evidence →
Cell Signaling TechnologyEvidence 66

Mouse (MOPC-21) Monoclonal Antibody IgG1 Isotype Control (Alexa Fluor® 647 Conjugate)

#4843$155
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 66

LshCas13a/C2c2 (Leptotrichia shahii) (7D1-H7) Mouse Monoclonal Antibody

Cited in 17 papers
#43731$158,348
View Evidence →
Cell Signaling TechnologyEvidence 67

Stat5 (3H7) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 7 papers
#57580$865
View Evidence →
Cell Signaling TechnologyEvidence 65

CD97 (F1B5E) Rabbit Monoclonal Antibody

Cited in 6 papers
#42684$178,415
View Evidence →